Search

everythinglearnresearchcommunity

for

Search:↓

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Non-immune factors play a significant role in alopecia areata.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

PRP and cell therapies may help with hair loss, but more research is needed.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Some alopecia treatments might help treat COVID-19, but more research is needed.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

Some alternative medicine treatments might work for skin conditions, but their effectiveness and safety differ a lot.

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Use trichoscopy to diagnose hair loss; treat with minoxidil, finasteride, or dutasteride; consider platelet-rich plasma and spironolactone.

Dermatologists often neglect hair disorders due to complexity and lack of clear treatments, impacting patient care and highlighting the need for better education and interest in this area.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Azathioprine may help treat severe alopecia areata, but more research is needed.